Exploring how sleep patterns affect diabetes management
Official title: Chronotype of Patients With Diabetes and Effect on Glycaemic Control: The CODEC Study
Run by University of Leicester · NCT02973412 · Data updated 2026-11-12
This study is trying to see how different sleep patterns affect diabetes management in people aged 18 to 75 who have been living with diabetes for over six months.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 3447 (estimated) |
| Sponsor | University of Leicester Academic / other |
| Locations | 1 site (Leicester) |
| Status | Recruiting |
| Started | December 7, 2016 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | February 15, 2024 |
| Trial ID | NCT02973412 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18-75 with Type 1 or established Type 2 diabetes who are managing their condition with therapy or lifestyle changes.
✕Probably not a fit
Patients with significant sleep disorders other than Obstructive Sleep Apnoea or those with terminal illnesses may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the relationship between chronotype, which refers to an individual's natural sleep-wake cycle, and glycaemic control in patients with Type 1 and Type 2 diabetes. It will assess how sleep patterns may influence cardiometabolic health and various lifestyle factors in individuals diagnosed with diabetes. The study will include participants aged 18 to 75 years who have been diagnosed with diabetes for over six months and are currently managing their condition with glucose-lowering therapy or lifestyle modifications. By understanding these associations, the study seeks to identify new approaches to enhance diabetes management.
Why it matters
Potential benefit: If successful, this study could lead to improved diabetes management strategies tailored to individual sleep patterns.
How similar studies have gone: While there has been growing interest in the impact of sleep on diabetes management, this specific approach exploring chronotype in relation to glycaemic control is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Participant is willing and able to give informed consent for participation in the study 2. T1DM or established T2DM (\>6months since diagnosis) 3. Male or Female 4. Aged 18-75 years inclusive 5. BMI less than or equal to 45kg/m² inclusive 6. No known sleep disorders except Obstructive Sleep Apnoea (OSA) 7. On any glucose-lowering therapy (T1DM or T2DM) or lifestyle modification for management of T2DM 8. Good command of the English language Exclusion Criteria: 1. Participant is unwilling or unable to give informed consent 2. Anyone without a good command of the English language 3. Anyone \<18 years of age and \>75 years of age 4. BMI greater than 45 kg/m² 5. A regular cannabis user i.e. weekly use 6. Have a terminal illness 7. A known sleep disorder that is not OSA 8. Regular use of the following medicines i.e. Weekly use: (Wakefulness promoting agents Modafinil, Amphetamine derivatives, Methylphenidate; Sedatives including benzodiazepines, Z-drugs (zopiclone, zolpidem \& zaleplon); Melatonin, including Circadin and melatonin analogues; Clonazepam and other drugs for nocturnal movement disorders).
Where it's running
-
Leicester Diabetes Centre, Leicester General Hospital
Leicester, United Kingdom Recruiting
Study contacts
- Principal investigator: Andrew Hall — Sleep Consultant
- Study coordinator: Sahar Khodabakhsh, PhD
- Email: sahar.khodabakhsh@uhl-tr.nhs.uk
- Phone: 0116258
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
Diabetes multimorbidity and a voice diary app to help self-manage
This study tests whether the Fabla-diabetesMM audio diary app is feasible and helpful for older adults with type 1 or type 2 diabetes who also have additional chronic conditions.
-
Eversense Gemini system with new flash glucose feature — testing accuracy and safety
This will test whether the Eversense Gemini wearable glucose monitor with a new flash feature gives accurate and safe glucose readings for adults with type 1 or type 2 diabetes.
-
Evaluating LY4057996 in Healthy Individuals and Those with Type 1 and Type 2 Diabetes
This study is testing a new drug called LY4057996 to see how well it is tolerated and what side effects it might have in healthy people and those with Type 1 or Type 2 diabetes.
-
Comparing single-session and multiple-session laser treatment for diabetic eye disease
This study is testing whether one session or multiple sessions of laser treatment works better for people with newly diagnosed diabetic eye disease to help them keep their vision and avoid complications.
-
Program to reduce food insecurity for hospitalized diabetics
This study tests whether providing better access to healthy meals and nutrition education can help hospitalized patients with diabetes feel better and improve their overall health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.